|
|
Article: ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
- Article from:
- U.S. Newswire
- Article date:
- April 8, 2008
CopyrightCopyright 2008 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: SCIENCE EDITORS
Contact: Robert Goldstein of ALS TDI, +1-617-441-7295,
rgoldstein@als.net; or Aaron Blank for the Allen Institute for Brain
Science, +1-206-343-1543, aaronblank@feareygroup.com
Long-term arrangement between two leading non-profit research
institutes designed to validate drug targets for the fatal
neurodegenerative disease that affects 30,000 Americans
CAMBRIDGE, Mass.,April 8, 2008/PRNewswire-USNewswire/--The ALS
Therapy Development Institute (ALS TDI) today announced it has
entered into an agreement with the Allen Institute for Brain Science
in Seattle, Wash. for in situhybridization (ISH) services using
diseased tissues from a preclinical animal model of amyotrophic ...